GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hoshi Iryo-Sanki Co Ltd (TSE:7634) » Definitions » Valuation Rank

Hoshi Iryo-Sanki Co (TSE:7634) Valuation Rank


View and export this data going back to 2000. Start your Free Trial

What is Hoshi Iryo-Sanki Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Hoshi Iryo-Sanki Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Hoshi Iryo-Sanki Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hoshi Iryo-Sanki Co (TSE:7634) Business Description

Traded in Other Exchanges
N/A
Address
7-11-18 Iriya, Adachi-ku, Tokyo, JPN, 121-0836
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceuticals products. It offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes production and supply of medical gas, home care, care assistive devices, medical gas maintenance, and others.